Carlos Alban, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 4,749 shares at $53.94 ($256K) on 2010-02-16, disclosed to the SEC on 2010-02-23.
Scheduled sale ($256k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.93 | 3,549 | $191K | 74.7% |
| 2 | $53.94 | 1,200 | $65K | 25.3% |
| Total | $53.93 avg | 4,749 | $256K | 100% |
| Filing → |
| ABBV | SELL | 2018-03-02 | $19.1M | — | Filing → |
| ABBV | SELL | 2017-06-15 | $3.2M | — | Filing → |
| ABBV | SELL | 2017-05-08 | $2.9M | — | Filing → |